INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
TH

Telman Deborah H

EVP, Corporate Affairs & GCCIK 0001860008

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 3
Max Insider Score22
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
TH
Telman Deborah HDirector
ATRCAtriCure, Inc.
Grant or award
A—
6,144 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    AtriCure, Inc.Director · May 20, 2026
  • Insider ofevidence
    GILEAD SCIENCES, INC.EVP, Corporate Affairs & GC · Nov 13, 2025
22
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL
$2.13M
17.2K sh
Nov 12, 2025
Nov 13, 2025
traded Nov 12, 2025
+1d
SEC FORM 4

Evidence

20
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$2.18M
36.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

22
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$4.40M
36.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

0
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$30K
500 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

16
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$1.29M
17.2K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

11
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
17.2K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

0
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
36.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

0
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
500 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

8
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$61K
500 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence